Peder was previously Head of Business Development and Strategy at Swedish Orphan Biovitrum and Swedish Orphan International, responsible for the company’s successful portfolio expansion as well as corporate strategy. Peder has a background as a management consultant with the Boston Consulting Group, focusing primarily on the life sciences sector, and has also served as Head of Business Development and New Products at Novartis Nordic. Peder is a registered physician with an MD from Uppsala University and also holds a BA in International Economics and Business Administration from the same university.
Kennet holds extensive experience from the marketing of niche specialty pharmaceuticals and orphan drugs. Most recently, Kennet served as CEO of Swedish Orphan Biovitrum and was previously Head of Marketing and Sales and later also deputy CEO at Swedish Orphan International, with responsibility for the international expansion and the establishment of subsidiaries in several European countries. Prior to Swedish Orphan, Kennet held various senior positions within Bristol-Myers Squibb both in Sweden and internationally, including Executive Director and Country Manager. Kennet holds a degree in Biology/Chemistry from Stockholm University and received General Management training at CEDEP/INSEAD.
Director Regulatory and Quality Assurance
Gudrun has long experience from the regulatory field, including the Swedish Medicinal Products Agency with experience from Named Patient Use approval and assistance in marketing authorization approvals and procedures. Prior to joining Medical Need, Gudrun was Head of Regulatory Affairs and Quality Assurance at Swedish Orphan International for over fifteen years. Where she through her responsibility for the company’s regulatory activities gained significant experience from the registration and maintenance of pharmaceuticals and orphan medicinal products across EU. Gudrun holds a Pharm. Mag. from the University of Uppsala.
Chairman of the Board of Directors